Sign In

Login

Password

Forgot Password ? Sign Up

Mielóma multiplex (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mielóma multiplex" in Hungarian language version.

refsWebsite
Global rank Hungarian rank
79nih.gov
4th place
11th place
49doi.org
2nd place
8th place
6archive.org
6th place
14th place
2web.archive.org
1st place
1st place
1cancer.gov
1,684th place
2,306th place
1cancerresearchuk.org
8,489th place
2,423rd place
1aafp.org
1,916th place
1,237th place
1amcp.org
low place
low place
1jstor.org
26th place
330th place

aafp.org

amcp.org

archive.org

cancer.gov

seer.cancer.gov

cancerresearchuk.org

doi.org

dx.doi.org

  • Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (2009. July). „Multiple myeloma” (angol nyelven). Lancet 374 (9686), 324–39. o. DOI:10.1016/S0140-6736(09)60221-X. PMID 19541364. 
  • Roodman GD. (2010. February). „Pathogenesis of myeloma bone disease.” (angol nyelven). J Cell Biochem. 109 (2), 283-91. o. DOI:10.1002/jcb.22403. PMID 20014067. 
  • Terpos E, Berenson J, Raje N, Roodman GD. (2014. February). „Management of bone disease in multiple myeloma.” (angol nyelven). Expert Rev Hematol. 7 (1), 113-25. o. DOI:10.1586/17474086.2013.874943. PMID 24433088. 
  • San-Miguel JF, Mateos MV. (2011. September). „Can multiple myeloma become a curable disease?” (angol nyelven). Haematologica. 96 (9), 1246-8. o. DOI:10.3324/haematol.2011.051169. PMID 21880640. 
  • Greenberg AJ, Vachon CM, Rajkumar SV. (2012. April). „Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.” (angol nyelven). Leukemia. 26 (4), 609-14. o. DOI:10.1038/leu.2011.368. PMID 22193966. 
  • Lozano R, Naghavi M, Foreman K, et al. (2012. December). „Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.” (angol nyelven). Lancet. 380 (9859), 2095-128. o. DOI:10.1016/S0140-6736(12)61728-0. PMID 23245604. 
  • Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. (2007). „Multiple myeloma: a review of the epidemiologic literature.” (angol nyelven). Int J Cancer. 120 (Suppl 12), 40-61. o. DOI:10.1002/ijc.22718. PMID 17405120. 
  • Koura DT, Langston AA. (2013. August). „Inherited predisposition to multiple myeloma.” (angol nyelven). Ther Adv Hematol. 4 (4), 291-7. o. DOI:10.1177/2040620713485375. PMID 23926460. 
  • Talamo G, Farooq U, Zangari M, Liao J, Dolloff NG, Loughran TP Jr, Epner E. (2010. December). „Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma.” (angol nyelven). Clin Lymphoma Myeloma Leuk. 10 (6), 464-8. o. DOI:10.3816/CLML.2010.n.080. PMID 21156463. 
  • Oranger A, Carbone C, Izzo M, Grano M. (2013. August). „Cellular mechanisms of multiple myeloma bone disease.” (angol nyelven). Clin Dev Immunol. 72013, 289458. o. DOI:10.1155/2013/289458. PMID 23818912. 
  • Buckle CH, De Leenheer E, Lawson MA, Yong K, Rabin N, Perry M, Vanderkerken K, Croucher PI. (2012. August). „Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.” (angol nyelven). PLoS One. 7 (8), e41127. o. DOI:10.1371/journal.pone.0041127. PMID 22952578. 
  • Tosi P. (2013). „Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement.” (angol nyelven). Scientifica (Cairo). 2013, 104546. o. DOI:10.1155/2013/104546. PMID 24381787. 
  • Suzuki K. (2012. October). „Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.” (angol nyelven). Clin Exp Nephrol. 16 (5), 659-71. o. DOI:10.1007/s10157-012-0684-5. PMID 22968855. 
  • Nucci M, Anaissie E. (2009. July). „Infections in patients with multiple myeloma.” (angol nyelven). Semin Hematol. 46 (3), 277-88. o. DOI:10.1053/j.seminhematol.2009.03.006. PMID 19549580. 
  • Kalambokis GN, Christou L, Tsianos EV. (2009. August). „Multiple myeloma presenting with an acute bacterial infection.” (angol nyelven). Int J Lab Hematol. 31 (4), 375-83. o. DOI:10.1111/j.1751-553X.2009.01154.x. PMID 19486365. 
  • Nucci M, Anaissie E. (2009. October). „Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.” (angol nyelven). Clin Infect Dis. 49 (8), 1211-25. o. DOI:10.1086/605664. PMID 19769539. 
  • Dispenzieri A, Kyle RA. (2005. December). „Neurological aspects of multiple myeloma and related disorders.” (angol nyelven). Best Pract Res Clin Haematol. 18 (4), 673-88. o. DOI:10.1016/j.beha.2005.01.024. PMID 16026744. 
  • Bladé J, Rosiñol L. (2007. December). „Complications of multiple myeloma.” (angol nyelven). Hematol Oncol Clin North Am. 21 (6), 1231-46. o. DOI:10.1016/j.hoc.2007.08.006. PMID 17996596. 
  • Sobol U, Stiff P. (2014. December). „Neurologic aspects of plasma cell disorders.” (angol nyelven). Handb Clin Neurol. 120, 1083-99. o. DOI:10.1016/B978-0-7020-4087-0.00073-5. PMID 24365373. 
  • Rajkumar SV. (2013. March). „Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management.” (angol nyelven). Am J Hematol. 88 (3), 226-35. o. DOI:10.1002/ajh.23390. PMID 23440663. 
  • Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. (2002. February). „A long-term study of prognosis in monoclonal gammopathy of undetermined significance.” (angol nyelven). N Engl J Med. 346 (8), 564-9. o. DOI:10.1056/NEJMoa01133202. PMID 11856795. 
  • Fernández de Larrea C, Kyle RA, Durie BG, et al. (2013. April). „Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.” (angol nyelven). Leukemia. 27 (4), 780-91. o. DOI:10.1038/leu.2012.336. PMID 23288300. 
  • Dimopoulos M, Terpos E, Comenzo RL, et al. (2009. September). „International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.” (angol nyelven). Leukemia. 23 (9), 1545-56. o. DOI:10.1038/leu.2009.89. PMID 19421229. 
  • Joffe J, Williams MP, Cherryman GR, Gore M, McElwain TJ, Selby P. (1988. May). „Magnetic resonance imaging in myeloma.” (angol nyelven). Lancet. 1 (8595), 1162-3. o. DOI:10.1016/S0140-6736(88)91973-3. PMID 2896977. 
  • Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M. (2005. July). „Role of MRI for the diagnosis and prognosis of multiple myeloma.” (angol nyelven). Eur J Radiol. 55 (1), 56-63. o. DOI:10.1016/j.ejrad.2005.01.017. PMID 15950101. 
  • Agarwal A, Chirindel A, Shah BA, Subramaniam RM. (2013. April). „Evolving role of FDG PET/CT in multiple myeloma imaging and management.” (angol nyelven). AJR Am J Roentgenol. 200 (4), 884-90. o. DOI:10.2214/AJR.12.9653. PMID 23521465. 
  • Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. (2011. May). „The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.” (angol nyelven). Blood. 117 (19), 5019-32.. o. DOI:10.1182/blood-2011-01-293050. PMID 21300984. 
  • Kyle RA, Rajkumar SV. (2009. January). „Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.” (angol nyelven). Leukemia. 23 (1), 3-9. o. DOI:10.1038/leu.2008.291. PMID 18971951. 
  • Kumar S, Kimlinger T, Morice W. (2010. September). „Immunophenotyping in multiple myeloma and related plasma cell disorders.” (angol nyelven). Best Pract Res Clin Haematol. 23 (3), 433-51. o. DOI:10.1016/j.beha.2010.09.002. PMID 21112041. 
  • Robillard N, Wuillème S, Moreau P, Béné MC. (2014. March). „Immunophenotype of normal and myelomatous plasma-cell subsets.” (angol nyelven). Front Immunol. 5, 137. o. DOI:10.3389/fimmu.2014.00137. PMID 24744760. 
  • Fonseca R, Bergsagel PL, Drach J, et al. (2009. December). „International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.” (angol nyelven). Leukemia. 23 (12), 2210-21. o. DOI:10.1038/leu.2009.174. PMID 19798094. 
  • Chng WJ, Winkler JM, Greipp PR, et al. (2006. March). „Ploidy status rarely changes in myeloma patients at disease progression.” (angol nyelven). Leuk Res. 30 (3), 266-71. o. DOI:10.1016/j.leukres.2005.07.004. PMID 16111750. 
  • Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. (1997. July). „Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.” (angol nyelven). Nat Genet. 16 (3), 260-7. o. DOI:10.1038/ng0797-260. PMID 9207791. 
  • Fonseca R, Blood E, Rue M, et al. (2003. June). „Clinical and biologic implications of recurrent genomic aberrations in myeloma.” (angol nyelven). Blood. 101 (11), 4569-75. o. DOI:10.1182/blood-2002-10-3017. PMID 12576322. 
  • Fonseca R, Blood EA, Oken MM, et al. (2002. May). „Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.” (angol nyelven). Blood. 99 (10), 3735-41. o. DOI:10.1182/blood.V99.10.3735. PMID 11986230. 
  • Greipp PR, San Miguel J, Durie BG, et al. (2005. May). „International staging system for multiple myeloma.” (angol nyelven). J Clin Oncol. 23 (15), 3412-20. o. DOI:10.1200/JCO.2005.04.242. PMID 15809451. 
  • Palumbo A, Rajkumar SV, San Miguel JF, et al. (2014. February). „International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.” (angol nyelven). J Clin Oncol. 32 (6), 587-600. o. DOI:10.1200/JCO.2013.48.7934. PMID 24419113. 
  • Lamers J, Hartmann M, Goldschmidt H, Brechtel A, Hillengass J, Herzog W. (2013. April). „Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what?” (angol nyelven). Psychooncology. 22 (10), 2313-20. o. DOI:10.1002/pon.3284. PMID 23576528. 
  • Engelhardt M, Terpos E, Kleber M, et al. (2014. February). „European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.” (angol nyelven). Haematologica. 99 (2), 232-42. o. DOI:10.3324/haematol.2013.099358. PMID 24497560. 
  • Shimoni A, Hardan I, Ayuk F, Schilling G, Atanackovic D, Zeller W, Yerushalmi R, Zander AR, Kroger N, Nagler A. (2010. August). „Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.” (angol nyelven). Cancer. 116 (15), 3621-30. o. DOI:10.1002/cncr.25228. PMID 20564132. 
  • San Miguel JF, Schlag R, Khuageva NK, et al. (2008. August). „Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.” (angol nyelven). N Engl J Med. 359 (9), 906-17. o. DOI:10.1056/NEJMoa0801479. PMID 18753647. 
  • Gasparetto C, Gockerman JP, Diehl LF, et al. (2010. January). „"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.” (angol nyelven). Biol Blood Marrow Transplant. 16 (1), 70-7. o. DOI:10.1016/j.bbmt.2009.08.017. PMID 19733251. 
  • Terpos E, Morgan G, Dimopoulos MA, et al. (2013. July). „International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.” (angol nyelven). J Clin Oncol. 31 (18), 2347-57. o. DOI:10.1200/JCO.2012.47.7901. PMID 23690408. 
  • Bouza C, López-Cuadrado T, Cediel P, Saz-Parkinson Z, Amate JM. (2009. September). „Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis.” (angol nyelven). BMC Palliat Care. 8, 12. o. DOI:10.1186/1472-684X-8-12. PMID 19740423. 
  • Balducci M, Chiesa S, Manfrida S, et al. (2011. February). „Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.” (angol nyelven). Strahlenther Onkol. 187 (2), 114-9. o. DOI:10.1007/s00066-010-2155-9. PMID 21336712. 
  • Palumbo A, Mateos MV, Bringhen S, San Miguel JF. (2011. July). „Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?” (angol nyelven). Blood Rev. 25 (4), 181-91. o. DOI:10.1016/j.blre.2011.03.005. PMID 21497966. 
  • Kumar SK, Rajkumar SV, Dispenzieri A, et al. (2008. March). „Improved survival in multiple myeloma and the impact of novel therapies.” (angol nyelven). Blood. 111 (5), 2516-20. o. DOI:10.1182/blood-2007-10-116129. PMID 17975015. 
  • Pulte D, Gondos A, Brenner H. (2011. October). „Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.” (angol nyelven). Oncologist. 16 (11), 1600-3. o. DOI:10.1634/theoncologist.2011-0229. PMID 21968047. 
  • Kyle RA, Steensma DP. (2011). „History of multiple myeloma.” (angol nyelven). Recent Results Cancer Res. 183, 3-23. o. DOI:10.1007/978-3-540-85772-3_1. PMID 21509678. 

jstor.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (2009. July). „Multiple myeloma” (angol nyelven). Lancet 374 (9686), 324–39. o. DOI:10.1016/S0140-6736(09)60221-X. PMID 19541364. 
  • Roodman GD. (2010. February). „Pathogenesis of myeloma bone disease.” (angol nyelven). J Cell Biochem. 109 (2), 283-91. o. DOI:10.1002/jcb.22403. PMID 20014067. 
  • Terpos E, Berenson J, Raje N, Roodman GD. (2014. February). „Management of bone disease in multiple myeloma.” (angol nyelven). Expert Rev Hematol. 7 (1), 113-25. o. DOI:10.1586/17474086.2013.874943. PMID 24433088. 
  • San-Miguel JF, Mateos MV. (2011. September). „Can multiple myeloma become a curable disease?” (angol nyelven). Haematologica. 96 (9), 1246-8. o. DOI:10.3324/haematol.2011.051169. PMID 21880640. 
  • Parkin DM, Bray F, Ferlay J, Pisani P. (2005. March-April). „Global cancer statistics, 2002.” (angol nyelven). CA Cancer J Clin. 55 (2), 74-108. o. PMID 15761078. 
  • Greenberg AJ, Vachon CM, Rajkumar SV. (2012. April). „Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.” (angol nyelven). Leukemia. 26 (4), 609-14. o. DOI:10.1038/leu.2011.368. PMID 22193966. 
  • Lozano R, Naghavi M, Foreman K, et al. (2012. December). „Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.” (angol nyelven). Lancet. 380 (9859), 2095-128. o. DOI:10.1016/S0140-6736(12)61728-0. PMID 23245604. 
  • Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. (2007). „Multiple myeloma: a review of the epidemiologic literature.” (angol nyelven). Int J Cancer. 120 (Suppl 12), 40-61. o. DOI:10.1002/ijc.22718. PMID 17405120. 
  • Koura DT, Langston AA. (2013. August). „Inherited predisposition to multiple myeloma.” (angol nyelven). Ther Adv Hematol. 4 (4), 291-7. o. DOI:10.1177/2040620713485375. PMID 23926460. 
  • Talamo G, Farooq U, Zangari M, Liao J, Dolloff NG, Loughran TP Jr, Epner E. (2010. December). „Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma.” (angol nyelven). Clin Lymphoma Myeloma Leuk. 10 (6), 464-8. o. DOI:10.3816/CLML.2010.n.080. PMID 21156463. 
  • Oranger A, Carbone C, Izzo M, Grano M. (2013. August). „Cellular mechanisms of multiple myeloma bone disease.” (angol nyelven). Clin Dev Immunol. 72013, 289458. o. DOI:10.1155/2013/289458. PMID 23818912. 
  • Buckle CH, De Leenheer E, Lawson MA, Yong K, Rabin N, Perry M, Vanderkerken K, Croucher PI. (2012. August). „Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma.” (angol nyelven). PLoS One. 7 (8), e41127. o. DOI:10.1371/journal.pone.0041127. PMID 22952578. 
  • Tosi P. (2013). „Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement.” (angol nyelven). Scientifica (Cairo). 2013, 104546. o. DOI:10.1155/2013/104546. PMID 24381787. 
  • Mittelman M. (2003. August). „The implications of anemia in multiple myeloma.” (angol nyelven). Clin Lymphoma. 4 (Suppl 1), s23-9. o. PMID 14556675. 
  • Ludwig H, Pohl G, Osterborg A. (2004. April). „Anemia in multiple myeloma.” (angol nyelven). Clin Adv Hematol Oncol. 2 (4), 233-41. o. PMID 16163188. 
  • Dammacco F, Luccarelli G, Prete M, Silvestris F. (2002). „The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma.” (angol nyelven). Rev Clin Exp Hematol. Suppl. 1, 32-8. o. PMID 12735213. 
  • Clark AD, Shetty A, Soutar R. (1999. June). „Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma.” (angol nyelven). Blood Rev. 13 (2), 79-90. o. PMID 10414944. 
  • Herrera GA. (2000. June). „Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.” (angol nyelven). Ann Diagn Pathol. 4 (3), 174-200. o. PMID 10919389. 
  • Ronco P, Plaisier E, Mougenot B, Aucouturier P. (2006. November). „Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.” (angol nyelven). Clin J Am Soc Nephrol. 1 (6), 1342-50. o. PMID 17699367. 
  • Suzuki K. (2012. October). „Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.” (angol nyelven). Clin Exp Nephrol. 16 (5), 659-71. o. DOI:10.1007/s10157-012-0684-5. PMID 22968855. 
  • Ganeval D, Lacour B, Chopin N, Grünfeld JP. (1990. November). „Proteinuria in multiple myeloma and related diseases.” (angol nyelven). Am J Nephrol. 10 (Suppl 1), 58-62. o. PMID 2124083. 
  • Nucci M, Anaissie E. (2009. July). „Infections in patients with multiple myeloma.” (angol nyelven). Semin Hematol. 46 (3), 277-88. o. DOI:10.1053/j.seminhematol.2009.03.006. PMID 19549580. 
  • Kalambokis GN, Christou L, Tsianos EV. (2009. August). „Multiple myeloma presenting with an acute bacterial infection.” (angol nyelven). Int J Lab Hematol. 31 (4), 375-83. o. DOI:10.1111/j.1751-553X.2009.01154.x. PMID 19486365. 
  • Hargreaves RM, Lea JR, Griffiths H, Faux JA, Holt JM, Reid C, Bunch C, Lee M, Chapel HM. (1995. March). „Immunological factors and risk of infection in plateau phase myeloma.” (angol nyelven). J Clin Pathol. 48 (3), 260-6. o. PMID 7730490. 
  • Ogawara H, Handa H, Yamazaki T, et al. (2005. February). „High Th1/Th2 ratio in patients with multiple myeloma.” (angol nyelven). Leuk Res. 29 (2), 135-40. o. PMID 15607360. 
  • Nucci M, Anaissie E. (2009. October). „Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.” (angol nyelven). Clin Infect Dis. 49 (8), 1211-25. o. DOI:10.1086/605664. PMID 19769539. 
  • Dispenzieri A, Kyle RA. (2005. December). „Neurological aspects of multiple myeloma and related disorders.” (angol nyelven). Best Pract Res Clin Haematol. 18 (4), 673-88. o. DOI:10.1016/j.beha.2005.01.024. PMID 16026744. 
  • Bladé J, Rosiñol L. (2007. December). „Complications of multiple myeloma.” (angol nyelven). Hematol Oncol Clin North Am. 21 (6), 1231-46. o. DOI:10.1016/j.hoc.2007.08.006. PMID 17996596. 
  • Sobol U, Stiff P. (2014. December). „Neurologic aspects of plasma cell disorders.” (angol nyelven). Handb Clin Neurol. 120, 1083-99. o. DOI:10.1016/B978-0-7020-4087-0.00073-5. PMID 24365373. 
  • Rajkumar SV. (2013. March). „Multiple myeloma: 2013 update on diagnosis, risk-stratification, and management.” (angol nyelven). Am J Hematol. 88 (3), 226-35. o. DOI:10.1002/ajh.23390. PMID 23440663. 
  • Abdalla IA, Tabbara IA. (2002. July). „Nonsecretory multiple myeloma.” (angol nyelven). South Med J. 95 (7), 761-4. o. PMID 12144086. 
  • Hamidah NH, Azma RZ, Ezalia E, et al. (2010). „Non-secretory multiple myeloma with diagnostic challenges.” (angol nyelven). Clin Ter. 161 (5), 445-8. o. PMID 20949241. 
  • Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ 3rd. (2002. February). „A long-term study of prognosis in monoclonal gammopathy of undetermined significance.” (angol nyelven). N Engl J Med. 346 (8), 564-9. o. DOI:10.1056/NEJMoa01133202. PMID 11856795. 
  • Fernández de Larrea C, Kyle RA, Durie BG, et al. (2013. April). „Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.” (angol nyelven). Leukemia. 27 (4), 780-91. o. DOI:10.1038/leu.2012.336. PMID 23288300. 
  • Dimopoulos M, Terpos E, Comenzo RL, et al. (2009. September). „International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.” (angol nyelven). Leukemia. 23 (9), 1545-56. o. DOI:10.1038/leu.2009.89. PMID 19421229. 
  • Joffe J, Williams MP, Cherryman GR, Gore M, McElwain TJ, Selby P. (1988. May). „Magnetic resonance imaging in myeloma.” (angol nyelven). Lancet. 1 (8595), 1162-3. o. DOI:10.1016/S0140-6736(88)91973-3. PMID 2896977. 
  • Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M. (2005. July). „Role of MRI for the diagnosis and prognosis of multiple myeloma.” (angol nyelven). Eur J Radiol. 55 (1), 56-63. o. DOI:10.1016/j.ejrad.2005.01.017. PMID 15950101. 
  • Agarwal A, Chirindel A, Shah BA, Subramaniam RM. (2013. April). „Evolving role of FDG PET/CT in multiple myeloma imaging and management.” (angol nyelven). AJR Am J Roentgenol. 200 (4), 884-90. o. DOI:10.2214/AJR.12.9653. PMID 23521465. 
  • Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. (2011. May). „The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.” (angol nyelven). Blood. 117 (19), 5019-32.. o. DOI:10.1182/blood-2011-01-293050. PMID 21300984. 
  • Kyle RA, Rajkumar SV. (2009. January). „Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.” (angol nyelven). Leukemia. 23 (1), 3-9. o. DOI:10.1038/leu.2008.291. PMID 18971951. 
  • Kumar S, Kimlinger T, Morice W. (2010. September). „Immunophenotyping in multiple myeloma and related plasma cell disorders.” (angol nyelven). Best Pract Res Clin Haematol. 23 (3), 433-51. o. DOI:10.1016/j.beha.2010.09.002. PMID 21112041. 
  • Ruiz-Argüelles GJ, San Miguel JF. (1994. July). „Cell surface markers in multiple myeloma.” (angol nyelven). Mayo Clin Proc. 69 (7), 684-90. o. PMID 8015335. 
  • Robillard N, Wuillème S, Moreau P, Béné MC. (2014. March). „Immunophenotype of normal and myelomatous plasma-cell subsets.” (angol nyelven). Front Immunol. 5, 137. o. DOI:10.3389/fimmu.2014.00137. PMID 24744760. 
  • Zandecki M, Laï JL, Facon T. (1996. August). „Multiple myeloma: almost all patients are cytogenetically abnormal.” (angol nyelven). Br J Haematol. 94 (2), 217-27. o. PMID 8759879. 
  • Fonseca R, Bergsagel PL, Drach J, et al. (2009. December). „International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.” (angol nyelven). Leukemia. 23 (12), 2210-21. o. DOI:10.1038/leu.2009.174. PMID 19798094. 
  • Chng WJ, Winkler JM, Greipp PR, et al. (2006. March). „Ploidy status rarely changes in myeloma patients at disease progression.” (angol nyelven). Leuk Res. 30 (3), 266-71. o. DOI:10.1016/j.leukres.2005.07.004. PMID 16111750. 
  • Drach J, Ackermann J, Fritz E, et al. (1998. August). „Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.” (angol nyelven). Blood. 92 (3), 802-9. o. PMID 9680348. 
  • Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. (1997. July). „Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.” (angol nyelven). Nat Genet. 16 (3), 260-7. o. DOI:10.1038/ng0797-260. PMID 9207791. 
  • Fonseca R, Blood E, Rue M, et al. (2003. June). „Clinical and biologic implications of recurrent genomic aberrations in myeloma.” (angol nyelven). Blood. 101 (11), 4569-75. o. DOI:10.1182/blood-2002-10-3017. PMID 12576322. 
  • Fonseca R, Blood EA, Oken MM, et al. (2002. May). „Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.” (angol nyelven). Blood. 99 (10), 3735-41. o. DOI:10.1182/blood.V99.10.3735. PMID 11986230. 
  • International Myeloma Working Group. (2003. June). „Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.” (angol nyelven). Br J Haematol. 121 (5), 749-57. o. PMID 12780789. 
  • Durie BG, Salmon SE. (1975. September). „A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.” (angol nyelven). Cancer. 36 (3), 842-54. o. PMID 1182674. 
  • Greipp PR, San Miguel J, Durie BG, et al. (2005. May). „International staging system for multiple myeloma.” (angol nyelven). J Clin Oncol. 23 (15), 3412-20. o. DOI:10.1200/JCO.2005.04.242. PMID 15809451. 
  • Nau KC, Lewis WD. (2008. October). „Multiple myeloma: diagnosis and treatment.” (angol nyelven). Am Fam Physician. 78 (7), 853-9. o. PMID 18841734. 
  • Palumbo A, Rajkumar SV, San Miguel JF, et al. (2014. February). „International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation.” (angol nyelven). J Clin Oncol. 32 (6), 587-600. o. DOI:10.1200/JCO.2013.48.7934. PMID 24419113. 
  • Cook R. (2008. September). „Economic and clinical impact of multiple myeloma to managed care.” (angol nyelven). J Manag Care Pharm. 14 (7 Suppl), 19-25. o. [2016. március 4-i dátummal az eredetiből archiválva]. PMID 18774882. (Hozzáférés: 2014. július 12.) 
  • Lamers J, Hartmann M, Goldschmidt H, Brechtel A, Hillengass J, Herzog W. (2013. April). „Psychosocial support in patients with multiple myeloma at time of diagnosis: who wants what?” (angol nyelven). Psychooncology. 22 (10), 2313-20. o. DOI:10.1002/pon.3284. PMID 23576528. 
  • Engelhardt M, Terpos E, Kleber M, et al. (2014. February). „European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.” (angol nyelven). Haematologica. 99 (2), 232-42. o. DOI:10.3324/haematol.2013.099358. PMID 24497560. 
  • Shimoni A, Hardan I, Ayuk F, Schilling G, Atanackovic D, Zeller W, Yerushalmi R, Zander AR, Kroger N, Nagler A. (2010. August). „Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.” (angol nyelven). Cancer. 116 (15), 3621-30. o. DOI:10.1002/cncr.25228. PMID 20564132. 
  • San Miguel JF, Schlag R, Khuageva NK, et al. (2008. August). „Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.” (angol nyelven). N Engl J Med. 359 (9), 906-17. o. DOI:10.1056/NEJMoa0801479. PMID 18753647. 
  • Gasparetto C, Gockerman JP, Diehl LF, et al. (2010. January). „"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.” (angol nyelven). Biol Blood Marrow Transplant. 16 (1), 70-7. o. DOI:10.1016/j.bbmt.2009.08.017. PMID 19733251. 
  • Terpos E, Morgan G, Dimopoulos MA, et al. (2013. July). „International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.” (angol nyelven). J Clin Oncol. 31 (18), 2347-57. o. DOI:10.1200/JCO.2012.47.7901. PMID 23690408. 
  • Bouza C, López-Cuadrado T, Cediel P, Saz-Parkinson Z, Amate JM. (2009. September). „Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis.” (angol nyelven). BMC Palliat Care. 8, 12. o. DOI:10.1186/1472-684X-8-12. PMID 19740423. 
  • Balducci M, Chiesa S, Manfrida S, et al. (2011. February). „Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience.” (angol nyelven). Strahlenther Onkol. 187 (2), 114-9. o. DOI:10.1007/s00066-010-2155-9. PMID 21336712. 
  • Palumbo A, Mateos MV, Bringhen S, San Miguel JF. (2011. July). „Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?” (angol nyelven). Blood Rev. 25 (4), 181-91. o. DOI:10.1016/j.blre.2011.03.005. PMID 21497966. 
  • Kumar SK, Rajkumar SV, Dispenzieri A, et al. (2008. March). „Improved survival in multiple myeloma and the impact of novel therapies.” (angol nyelven). Blood. 111 (5), 2516-20. o. DOI:10.1182/blood-2007-10-116129. PMID 17975015. 
  • Pulte D, Gondos A, Brenner H. (2011. October). „Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data.” (angol nyelven). Oncologist. 16 (11), 1600-3. o. DOI:10.1634/theoncologist.2011-0229. PMID 21968047. 
  • Zink A, Rohrbach H, Szeimies U, Hagedorn HG, Haas CJ, Weyss C, Bachmeier B, Nerlich AG. (1999. September-October). „Malignant tumors in an ancient Egyptian population.” (angol nyelven). Anticancer Res. 19 (5B), 4273-7. o. PMID 10628386. 
  • Solly S. (1844). „Remarks on the pathology of mollities ossium; with cases.” (angol nyelven). Med Chir Trans. 27, 435-61. o. PMID 20895811. 
  • Kyle RA, Steensma DP. (2011). „History of multiple myeloma.” (angol nyelven). Recent Results Cancer Res. 183, 3-23. o. DOI:10.1007/978-3-540-85772-3_1. PMID 21509678. 
  • Weber FP, Hutchison R, Macleod JJ. (1903). „A Case of Multiple Myeloma (Myelomatosis) with Bence-Jones Proteid in the Urine (Myelopathic Albumosuria of Bradshaw, Kahler's Disease), and a Summary of Published Cases of Bence-Jones Albumosuria: With a Report on the Chemical Pathology.” (angol nyelven). Med Chir Trans. 86, 395-470. o. PMID 20897004. 
  • Wright JH. (1900. April). „A case of multiple myeloma.” (angol nyelven). J Boston Soc Med Sci. 4 (8), 195-204. o. PMID 19971313. 
  • Longsworth LG, Shedlovsky T, Macinnes DA (1939. September). „Electrophoretic patterns of normal and pathological human blood serum and plasma.” (angol nyelven). J Exp Med. 70 (4), 399-413. o. PMID 19870918. 
  • Waldenstrom J. (1960-1961). „Studies on conditions associated with disturbed gamma globulin formation (gammopathies).” (angol nyelven). Harvey Lect. 56, 211-31. o. PMID 14004528. 
  • Matus RE, Leifer CE, MacEwen EG, Hurvitz AI. (1986. June). „Prognostic factors for multiple myeloma in the dog.” (angol nyelven). J Am Vet Med Assoc. 188 (11), 1288-92. o. PMID 3721983. 
  • Patel RT, Caceres A, French AF, McManus PM. (2005. December). „Multiple myeloma in 16 cats: a retrospective study.” (angol nyelven). Vet Clin Pathol. 34 (4), 341-52. o. PMID 16270258. 
  • Edwards DF, Parker JW, Wilkinson JE, Helman RG. title=Plasma cell myeloma in the horse. A case report and literature review. (1993. May-June). „{{{title}}}” (angol nyelven). J Vet Intern Med. 7 (3), 169-76. o. PMID 8331611. 
  • Gadó K, Silva S, Pálóczi K, Domján G, Falus A. (2001. March). „Mouse plasmacytoma: an experimental model of human multiple myeloma.” (angol nyelven). Haematologica. 86 (3), 227-36. o. PMID 11255268. 
  • Melixetian MB, Pavlenko MA, Beriozkina EV, Kovaleva ZV, Sorokina EA, Ignatova TN, Grinchuk TM. (2003. October). „Mouse myeloma cell line Sp2/0 multidrug-resistant variant as parental cell line for hybridoma construction.” (angol nyelven). Hybrid Hybridomics. 22 (5), 321-7. o. PMID 14678650. 

web.archive.org